Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Guilherme H. Furtado"'
Autor:
Guilherme H. Furtado, Jaime Rocha, Ricardo Hayden, Caitlyn Solem, Cynthia Macahilig, Wing Yu Tang, Richard Chambers, Maria Lavínea Novis de Figueiredo, Courtney Johnson, Jennifer Stephens, Seema Haider
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 23, Iss 2, Pp 86-94 (2019)
Background: Early antibiotic switch and early discharge protocols have not been widely studied in Latin America. Our objective was to describe real-world treatment patterns, resource use, and estimate opportunities for early switch from intravenous t
Externí odkaz:
https://doaj.org/article/6c5f39e3528940f9ae45da485a43c952
Autor:
Maria Virginia Villegas, MD, MSc, David Felipe Briceno, MD, Sory Jamil Ruiz, MD, Guilherme H. Furtado, MD, David P. Nicolau, PharmD, FCCP, FIDSA
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 5, Pp 413-419 (2011)
Objectives: This study was designed to simulate standard and optimized dosing regimens for intravenous antibiotics against contemporary populations of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa using
Externí odkaz:
https://doaj.org/article/3dee64609ab14bcf9d9bf667dcab9b6a
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 37(11)
To evaluate trends and the immediate and late impact of antimicrobial consumption on carbapenem-resistant Acinetobacter spp. (CRAs), carbapenem-resistant Pseudomonas aeruginosa (CRPA), and carbapenem-resistant Klebsiella spp. (CRKs) over a 10-year pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::090e40aec45783b8fcda5a0bebe4a0ab
https://pubmed.ncbi.nlm.nih.gov/30112695
https://pubmed.ncbi.nlm.nih.gov/30112695
Autor:
Maria Virginia Villegas, David Felipe Briceno, Sory Jamil Ruiz, Guilherme H Furtado, David P Nicolau
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 5, Pp 413-419
OBJECTIVES: This study was designed to simulate standard and optimized dosing regimens for intravenous antibiotics against contemporary populations of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa using
Externí odkaz:
https://doaj.org/article/0c17f37c09d94efbbdcba43439699292